[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368413-105":59,"doc-detail-368413-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","associations-between-plasma-and-urinary-heavy-metal-concentrations-and-the-risk-of-prostate-cancer","Associations between plasma and urinary heavy metal concentrations and the risk of prostate cancer","","Associations between plasma and urinary heavy metal concentrations and the risk of prostate cancer explores whether specific heavy metals contribute to the progression of prostate disease and may serve as biomarkers for early diagnosis. The study analyzes heavy metal concentrations in plasma and urine across patients with benign prostatic hyperplasia, precancerous lesions, and prostate cancer, alongside key clinical parameters such as age, total PSA, hemoglobin, and monocyte/lymphocyte ratio. Results show significant differences for vanadium and antimony in plasma, where lower antimony correlates with higher PC risk and higher vanadium appears in the PL group. Regression analyses support links between heavy metal levels and the risk of PL and PC, highlighting vanadium and copper as potential biomarkers or therapeutic targets. The research also finds a significant association between urinary lead concentration and PC risk, emphasizing complex interactions that warrant further mechanistic and intervention studies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/associations-between-plasma-and-urinary-heavy-metal-concentrations-and-the-risk-of-prostate-cancer/368413/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/associations-between-plasma-and-urinary-heavy-metal-concentrations-and-the-risk-of-prostate-cancer/368413.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study?","Question",{"text":113,"@type":114},"To assess whether heavy metal concentrations in plasma and urine are associated with the progression of prostate disease and whether they could function as biomarkers for early diagnosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which heavy metals show significant plasma differences in the findings?",{"text":118,"@type":114},"Vanadium and antimony concentrations in plasma differ significantly, with lower antimony linked to increased prostate cancer risk and higher vanadium observed in the precancerous lesion group.",{"name":120,"@type":111,"acceptedAnswer":121},"How is lead exposure connected to prostate cancer risk?",{"text":122,"@type":114},"The study reports a significant association between urine lead concentration and prostate cancer risk.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368413,1790219635,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAssociations between plasma and urinary heavy metal concentrationsand the risk of prostate cancer  \nDonatella Coradduzza1, Andrea Sanna2, Biagio Di Lorenzo1, Antonella Congiargiu1, Sonia Marra3,4, Maurizio Cossu2, Alessandro Tedde3,4, Maria Rosaria De Miglio3, Angelo Zinellu1, ArduinoA. Mangoni5, Alessio Aligio Cogoni6, Massimo Madonia3,4, Ciriaco Carru1,6 & Serenella Medici7􀀍  \nProstate cancer is a leading cause of morbidity and mortality worldwide, with incidence rates projected to double between 2020 and 2040. This growing health challenge highlights the need for improved diagnostic strategies and risk assessment tools to better understand disease etiology and progression. Among environmental factors, heavy metals have been implicated in inflammation and carcinogenesis, yet their specific role in prostate disease remains insufficiently explored. This novel study analyses the relationship between heavy metal concentrations in plasma and urine of patients with benign prostatic hyperplasia, precancerous lesions and prostate cancer. In addition to evaluating key clinical parameters, including age, total PSA levels, hemoglobin concentrations and monocyte/lymphocyte ratio, it aims to determine whether specific heavy metals contribute to the progression of prostate disease and whether they can serve as potential biomarkers for early diagnosis. Our findings reveal significant differences in vanadium and antimony concentrations in plasma, suggesting a potential role in prostate disease pathophysiology. Notably, lower plasma antimony concentrations are associated with an increased risk of PC, while plasma vanadium concentrations are significantly higher in the PL group. Regression analysis further supports the association between heavy metal concentrations and the risk of PL and PC, highlighting the potential of vanadium and copper as biomarkers or therapeutic targets for prostate health. The study also explores the impact of lead exposure on prostate cancer risk, revealing a significant association between urine lead concentration and PC. These findings underscore the complex interaction between heavy metal concentrations and prostate disease risk, emphasizing the need for further research to elucidate underlying mechanisms and explore therapeutic interventions.  \nKeywords Biomarkers, Prostate cancer, Heavy metal, Cancer risk, Inductively coupled plasma mass spectrometry (ICP-MS)  \nProstate cancer (PC) is the second most common cancer in men, with over a million cases diagnosed globally in 2018, representing 15% of all cancers1–3. The Lancet Commission has recently published projections indicating a significant increase in PC cases from 1.4 million in 2020 to 2.9 million by 2040, particularly in low and middleincome countries4. This increase cannot be prevented with lifestyle changes or public health interventions only, highlighting the need for alternative strategies5,6. The Commission also emphasizes the importance of improving early diagnosis and developing more effective treatments7–9.  \nThe burden of PC is mainly attributed to several factors, including family history, hormones, ethnicity, aging, and inflammatory states10–13. Chronic inflammation plays a critical role in the development of PC. Exposure to heavy metals may favour chronic inflammation14, 15. Heavy metals are not univocally defined, as their classification can be also based on their physical–chemical properties16. Broadly speaking, they include the d-and f-block transition elements, together with p-block metals and some non-metals like selenium and arsenic17. Their biological role can vary from essential to toxic. Essential trace elements, like iron, copper, cobalt,  \n1Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy. 2SC Chimica Istituto Zooprofilattico Sperimentale della Sardegna, Via Duca degli Abruzzi, 8, 07100 Sassari, Italy. 3Department of Medicine, ","cbCairHF0Bpy3tKh","https://ap.wps.com/l/cbCairHF0Bpy3tKh","pdf",2298256,"English","# Abstract/Overview\n## Study aims and clinical parameters\n## Key findings (vanadium, antimony, copper)\n## Lead exposure and prostate cancer risk\n## Significance and need for further research","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To assess whether heavy metal concentrations in plasma and urine are associated with the progression of prostate disease and whether they could function as biomarkers for early diagnosis.\"},{\"question\":\"Which heavy metals show significant plasma differences in the findings?\",\"answer\":\"Vanadium and antimony concentrations in plasma differ significantly, with lower antimony linked to increased prostate cancer risk and higher vanadium observed in the precancerous lesion group.\"},{\"question\":\"How is lead exposure connected to prostate cancer risk?\",\"answer\":\"The study reports a significant association between urine lead concentration and prostate cancer risk.\"}]","Associations between plasma and urinary heavy metal concentrations and the risk of prostate cancer | PDF",1790176829,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ba2b11879e9a04581aa3fcc8eaf428e.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb02245767542d37a053f1dd582f719f.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e2c1c84e6e3647e7fecf1333c6cea59.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9900400d079c26b493549acedc116272.webp",980,1287]